SlideShare uma empresa Scribd logo
1 de 56
Two Decades of Progress in  Retinal Degeneration Research: 1990-2011 From Scientific Darkness to the Light of Clinical Trials   ohenetihool L Gerald J. Chader, Ph.D., M.D.hc Doheny Eye Institute Los Angeles, CA USA os Angeles, CA University atlo October 22, 2009
What is Our Goal? ,[object Object]
How do we get  to our Goal?  ,[object Object],[object Object],[object Object],[object Object]
So Let’s look at some of the Progress in RP Genetics….. ,[object Object],[object Object],[object Object]
Genes for Rare Diseases ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Also, Progress in Cell Biology ,[object Object],[object Object],[object Object]
Now, What Are the  Major Contributing Factors To The AMD Disease Process? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Basic Science Summary ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object]
The first disease situation is… ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The second disease situation is… ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
1) Photoreceptor Transplantation ,[object Object],[object Object],[object Object],[object Object]
1) Stem Cell Transplantation ,[object Object],[object Object],[object Object]
Q.:  For RP,  Can We Actually Transform Stem Cells into Mature Photoreceptor Cells? ,[object Object],[object Object]
Q.: Are There Sources of Stem Cells Other  Than Embryonic? ,[object Object],[object Object],[object Object],[object Object]
In AMD,  the Focus is on  Stem Cells  Replenishing the  RPE Cell  L ayer ,[object Object],[object Object],[object Object],[object Object]
Clinical Trials? ,[object Object],[object Object],[object Object],[object Object]
Future Treatment? ,[object Object],[object Object],[object Object],[object Object]
2 ) Artificial Vision ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical Trials? ,[object Object],[object Object]
Status of Present SSMP Clinical Trial  and Future Work to Restore More Useful Vision  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Testing: Object Recognition with Argus 1
Testing: Comparing Object Recognition using  Argus 1 vs. Argus 2 Argus I (16 Electrodes)* Argus II (60 Electrodes) *AJO  2007, 143:820-827 Visual performance using a retinal prosthesis in three subjects with retinitis pigmentosa. Yani et al. 15 sec 2 sec
Argus II patients  Can Read Letters and Words Courtesy Drs. da Cruz and Webster (Moorfields Eye Hospital, London)
Argus II Subjects Can Identify Numbers Courtesy Drs Sahel, Barale, Said, Scheer  (Quinze-Vingts, Paris, France)
[object Object],[object Object],[object Object],Improvement in Orientation and  Mobility Tasks with the Argus 2:
Future Treatments? ,[object Object],[object Object],[object Object]
This is  NOT  Vision of Terminator or Geordi from Star Trek…..Yet
Cortical Implant (Dobelle)
3) Optical Photoswitches ,[object Object],[object Object],[object Object],[object Object]
Future Treatments? ,[object Object],[object Object],[object Object],[object Object]
Remember that the second disease  situation is…… ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
4) Neuroprotection  ,[object Object],[object Object],[object Object],[object Object]
Neuroprotection: Clinical Trials? ,[object Object],[object Object],[object Object],[object Object]
Future Treatments? ,[object Object],[object Object],[object Object]
Drugs: Valproic Acid ,[object Object],[object Object],[object Object],[object Object],[object Object]
For dry AMD , there Are  Possible Treatments Using Small Molecule Drugs  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
AMD: A Complex Disease ,[object Object],[object Object],[object Object]
5) Wet AMD    Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
What’s New? ,[object Object],[object Object],[object Object],[object Object]
  New Player in Field:  VEGF Trap  from   Regeneron  ,[object Object],[object Object],[object Object]
Trials using Gene Therapy:  ,[object Object],[object Object],[object Object],[object Object]
6) Antioxidants ,[object Object],[object Object],[object Object]
Antioxidant Trial ,[object Object],[object Object],[object Object],[object Object],[object Object]
Are There Other Antioxidant Trials? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Future Treatments? ,[object Object],[object Object],[object Object],[object Object]
7) Gene Therapy ,[object Object],[object Object],[object Object]
Extensive Preclinical  Gene Therapy Studies ,[object Object],[object Object],[object Object]
Gene Therapy Clinical Trials ,[object Object],[object Object],[object Object],[object Object]
Future Treatments? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
In Conclusion…. ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],In Conclusion….
So, looking back  on 1990-today…. ,[object Object],[object Object]
THANK YOU FOR YOUR ATTENTION!
Another Wet AMD Clinical Trial - RPE Cell Transplantation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Other Trials include… ,[object Object],[object Object],[object Object],[object Object],[object Object]

Mais conteúdo relacionado

Mais procurados

Loss of photoreceptor potential from retinal progenitor cell cultures, despit...
Loss of photoreceptor potential from retinal progenitor cell cultures, despit...Loss of photoreceptor potential from retinal progenitor cell cultures, despit...
Loss of photoreceptor potential from retinal progenitor cell cultures, despit...
Dr Reaz Vawda, MSc PhD
 
Optogenetics
OptogeneticsOptogenetics
Optogenetics
stowe11c
 
Presentacion Biologia Molecular
Presentacion Biologia MolecularPresentacion Biologia Molecular
Presentacion Biologia Molecular
alejocr707
 
New innovation in chemistry
New innovation in chemistryNew innovation in chemistry
New innovation in chemistry
anoop kp
 
Dna Technology
Dna TechnologyDna Technology
Dna Technology
annperry09
 
Forensic dna fingerprinting
Forensic dna fingerprintingForensic dna fingerprinting
Forensic dna fingerprinting
José Cruz
 
WBRT vs GK Surgery_Cooper Univ_1507167_WhitePaper1
WBRT vs GK Surgery_Cooper Univ_1507167_WhitePaper1WBRT vs GK Surgery_Cooper Univ_1507167_WhitePaper1
WBRT vs GK Surgery_Cooper Univ_1507167_WhitePaper1
Jerry Duncan
 

Mais procurados (18)

CREATING AN ULTRASOUND TEAM
CREATING AN ULTRASOUND TEAMCREATING AN ULTRASOUND TEAM
CREATING AN ULTRASOUND TEAM
 
Making Optical and Electrophysiological Measurements in the Brain of Head-Fix...
Making Optical and Electrophysiological Measurements in the Brain of Head-Fix...Making Optical and Electrophysiological Measurements in the Brain of Head-Fix...
Making Optical and Electrophysiological Measurements in the Brain of Head-Fix...
 
Loss of photoreceptor potential from retinal progenitor cell cultures, despit...
Loss of photoreceptor potential from retinal progenitor cell cultures, despit...Loss of photoreceptor potential from retinal progenitor cell cultures, despit...
Loss of photoreceptor potential from retinal progenitor cell cultures, despit...
 
Optogenetics
OptogeneticsOptogenetics
Optogenetics
 
Discovery Over a NGLY1 deficiency Knowledge Graph
Discovery Over a NGLY1 deficiency Knowledge GraphDiscovery Over a NGLY1 deficiency Knowledge Graph
Discovery Over a NGLY1 deficiency Knowledge Graph
 
Optogenetics
OptogeneticsOptogenetics
Optogenetics
 
Presentacion Biologia Molecular
Presentacion Biologia MolecularPresentacion Biologia Molecular
Presentacion Biologia Molecular
 
Dna repair
Dna repairDna repair
Dna repair
 
New innovation in chemistry
New innovation in chemistryNew innovation in chemistry
New innovation in chemistry
 
Cadmium Case Study
Cadmium Case StudyCadmium Case Study
Cadmium Case Study
 
Stem cell research in Parkinson's Disease
Stem cell research  in Parkinson's DiseaseStem cell research  in Parkinson's Disease
Stem cell research in Parkinson's Disease
 
Dna Technology
Dna TechnologyDna Technology
Dna Technology
 
Forensic dna fingerprinting
Forensic dna fingerprintingForensic dna fingerprinting
Forensic dna fingerprinting
 
UBM Presentation
UBM PresentationUBM Presentation
UBM Presentation
 
Pallavi ranjan
Pallavi ranjanPallavi ranjan
Pallavi ranjan
 
Michael Gutkin (Biology)
Michael Gutkin (Biology)Michael Gutkin (Biology)
Michael Gutkin (Biology)
 
Future Therapy For Neurodegenerative Diseases
Future Therapy For Neurodegenerative DiseasesFuture Therapy For Neurodegenerative Diseases
Future Therapy For Neurodegenerative Diseases
 
WBRT vs GK Surgery_Cooper Univ_1507167_WhitePaper1
WBRT vs GK Surgery_Cooper Univ_1507167_WhitePaper1WBRT vs GK Surgery_Cooper Univ_1507167_WhitePaper1
WBRT vs GK Surgery_Cooper Univ_1507167_WhitePaper1
 

Destaque

Transgenic organisms powerpoint
Transgenic organisms powerpointTransgenic organisms powerpoint
Transgenic organisms powerpoint
14wilsst
 
Dr Giridhar on RO - Ray of Hope?
Dr Giridhar on RO - Ray of Hope?Dr Giridhar on RO - Ray of Hope?
Dr Giridhar on RO - Ray of Hope?
retinaindia
 
Retina Review - Part 2
Retina Review - Part 2Retina Review - Part 2
Retina Review - Part 2
eyedoc34
 
Retinitis pigmentosa
Retinitis pigmentosaRetinitis pigmentosa
Retinitis pigmentosa
Mariam kashif
 
VASCULAR AND HEREDITARY RETINAL DISEASE
VASCULAR AND HEREDITARY RETINAL DISEASEVASCULAR AND HEREDITARY RETINAL DISEASE
VASCULAR AND HEREDITARY RETINAL DISEASE
Hossein Mirzaie
 

Destaque (20)

Transgenic organisms powerpoint
Transgenic organisms powerpointTransgenic organisms powerpoint
Transgenic organisms powerpoint
 
Dr Giridhar on RO - Ray of Hope?
Dr Giridhar on RO - Ray of Hope?Dr Giridhar on RO - Ray of Hope?
Dr Giridhar on RO - Ray of Hope?
 
Transgenic animals new
Transgenic animals newTransgenic animals new
Transgenic animals new
 
Animal models
Animal modelsAnimal models
Animal models
 
Nw2016 retinitis pigmentosa
Nw2016 retinitis pigmentosaNw2016 retinitis pigmentosa
Nw2016 retinitis pigmentosa
 
Knock out mice
Knock out miceKnock out mice
Knock out mice
 
Retinitis pigmentosa
Retinitis pigmentosaRetinitis pigmentosa
Retinitis pigmentosa
 
KnockOut mouse technology By Bikash karki
KnockOut mouse technology By Bikash karkiKnockOut mouse technology By Bikash karki
KnockOut mouse technology By Bikash karki
 
Knock out technology (final)
Knock out technology (final)Knock out technology (final)
Knock out technology (final)
 
Retina Review - Part 2
Retina Review - Part 2Retina Review - Part 2
Retina Review - Part 2
 
Gene knockout
Gene knockoutGene knockout
Gene knockout
 
Mouse model: Pros & Cons
Mouse model: Pros & ConsMouse model: Pros & Cons
Mouse model: Pros & Cons
 
Retinitis pigmentosa
Retinitis pigmentosaRetinitis pigmentosa
Retinitis pigmentosa
 
Knockout mice
Knockout miceKnockout mice
Knockout mice
 
Retinitis pigmentosa 1
Retinitis pigmentosa 1Retinitis pigmentosa 1
Retinitis pigmentosa 1
 
Transgenic Animals
Transgenic AnimalsTransgenic Animals
Transgenic Animals
 
Retinitis pigmentosa
Retinitis pigmentosaRetinitis pigmentosa
Retinitis pigmentosa
 
VASCULAR AND HEREDITARY RETINAL DISEASE
VASCULAR AND HEREDITARY RETINAL DISEASEVASCULAR AND HEREDITARY RETINAL DISEASE
VASCULAR AND HEREDITARY RETINAL DISEASE
 
Crispr/cas9 101
Crispr/cas9 101Crispr/cas9 101
Crispr/cas9 101
 
artificial eye
artificial eyeartificial eye
artificial eye
 

Semelhante a Dr Gerry Chader - AGM 2011 - Research Advancements

Presentation at Stem Cells USA & Regenerative medicine Congress 2011 in Bosto...
Presentation at Stem Cells USA & Regenerative medicine Congress 2011 in Bosto...Presentation at Stem Cells USA & Regenerative medicine Congress 2011 in Bosto...
Presentation at Stem Cells USA & Regenerative medicine Congress 2011 in Bosto...
Advanced Cell Technology, Inc.
 
Presentation at the Rodman & Renshaw Global Investment Conference, NYC, Sept....
Presentation at the Rodman & Renshaw Global Investment Conference, NYC, Sept....Presentation at the Rodman & Renshaw Global Investment Conference, NYC, Sept....
Presentation at the Rodman & Renshaw Global Investment Conference, NYC, Sept....
Advanced Cell Technology, Inc.
 
Presentation at Stem Cell Meeting on the Mesa, La Jolla, Calif., November 30,...
Presentation at Stem Cell Meeting on the Mesa, La Jolla, Calif., November 30,...Presentation at Stem Cell Meeting on the Mesa, La Jolla, Calif., November 30,...
Presentation at Stem Cell Meeting on the Mesa, La Jolla, Calif., November 30,...
Advanced Cell Technology, Inc.
 
Act corporate-presentationfeb13
Act corporate-presentationfeb13Act corporate-presentationfeb13
Act corporate-presentationfeb13
Company Spotlight
 
Positron emission tomographic scan
Positron emission tomographic scanPositron emission tomographic scan
Positron emission tomographic scan
Prashant Makhija
 
Dr. Tsang: Stem Cell Treatment Research and Its Possible Applicability to Ach...
Dr. Tsang: Stem Cell Treatment Research and Its Possible Applicability to Ach...Dr. Tsang: Stem Cell Treatment Research and Its Possible Applicability to Ach...
Dr. Tsang: Stem Cell Treatment Research and Its Possible Applicability to Ach...
AchromatopsiaConvention
 
Act corporate presentation may 2014 - print version
Act corporate presentation   may 2014 - print versionAct corporate presentation   may 2014 - print version
Act corporate presentation may 2014 - print version
John Redaelli
 
The Lancet - Human embryonic stem cell-derived retinal pigment epithelium in...
The Lancet - Human embryonic stem cell-derived retinal pigment  epithelium in...The Lancet - Human embryonic stem cell-derived retinal pigment  epithelium in...
The Lancet - Human embryonic stem cell-derived retinal pigment epithelium in...
John Redaelli
 

Semelhante a Dr Gerry Chader - AGM 2011 - Research Advancements (20)

Presentation at Stem Cells USA & Regenerative medicine Congress 2011 in Bosto...
Presentation at Stem Cells USA & Regenerative medicine Congress 2011 in Bosto...Presentation at Stem Cells USA & Regenerative medicine Congress 2011 in Bosto...
Presentation at Stem Cells USA & Regenerative medicine Congress 2011 in Bosto...
 
2 2. hyung min chung ppt
2 2. hyung min chung ppt2 2. hyung min chung ppt
2 2. hyung min chung ppt
 
Presentation at World Stem Cell & Regenerative Medicine Congress, London. May...
Presentation at World Stem Cell & Regenerative Medicine Congress, London. May...Presentation at World Stem Cell & Regenerative Medicine Congress, London. May...
Presentation at World Stem Cell & Regenerative Medicine Congress, London. May...
 
Roth Capital 24th Annual Growth Stock Conference, Los Angeles
Roth Capital 24th Annual Growth Stock Conference, Los AngelesRoth Capital 24th Annual Growth Stock Conference, Los Angeles
Roth Capital 24th Annual Growth Stock Conference, Los Angeles
 
Presentation at the Rodman & Renshaw Global Investment Conference, NYC, Sept....
Presentation at the Rodman & Renshaw Global Investment Conference, NYC, Sept....Presentation at the Rodman & Renshaw Global Investment Conference, NYC, Sept....
Presentation at the Rodman & Renshaw Global Investment Conference, NYC, Sept....
 
INDUCED PLURIPOTENT STEM CELL AND GENOME ENGINEERING
INDUCED PLURIPOTENT STEM CELL AND GENOME ENGINEERINGINDUCED PLURIPOTENT STEM CELL AND GENOME ENGINEERING
INDUCED PLURIPOTENT STEM CELL AND GENOME ENGINEERING
 
Presentation at Stem Cell Meeting on the Mesa, La Jolla, Calif., November 30,...
Presentation at Stem Cell Meeting on the Mesa, La Jolla, Calif., November 30,...Presentation at Stem Cell Meeting on the Mesa, La Jolla, Calif., November 30,...
Presentation at Stem Cell Meeting on the Mesa, La Jolla, Calif., November 30,...
 
2012 World Stem Cell & Regenerative Medicine Congress, London
2012 World Stem Cell & Regenerative Medicine Congress, London2012 World Stem Cell & Regenerative Medicine Congress, London
2012 World Stem Cell & Regenerative Medicine Congress, London
 
Design and Conduct of Preclinical and Clinical Trial in Opthalmology
Design and Conduct of Preclinical and Clinical Trial in OpthalmologyDesign and Conduct of Preclinical and Clinical Trial in Opthalmology
Design and Conduct of Preclinical and Clinical Trial in Opthalmology
 
Dr rachael pearson
Dr rachael pearsonDr rachael pearson
Dr rachael pearson
 
Act corporate-presentationfeb13
Act corporate-presentationfeb13Act corporate-presentationfeb13
Act corporate-presentationfeb13
 
BIO CEO & Investor Conference, New York City, February 11, 2013
BIO CEO & Investor Conference, New York City, February 11, 2013BIO CEO & Investor Conference, New York City, February 11, 2013
BIO CEO & Investor Conference, New York City, February 11, 2013
 
Transhumanism-reasonablefaith-adelaide
Transhumanism-reasonablefaith-adelaideTranshumanism-reasonablefaith-adelaide
Transhumanism-reasonablefaith-adelaide
 
Positron emission tomographic scan
Positron emission tomographic scanPositron emission tomographic scan
Positron emission tomographic scan
 
Dr. Tsang: Stem Cell Treatment Research and Its Possible Applicability to Ach...
Dr. Tsang: Stem Cell Treatment Research and Its Possible Applicability to Ach...Dr. Tsang: Stem Cell Treatment Research and Its Possible Applicability to Ach...
Dr. Tsang: Stem Cell Treatment Research and Its Possible Applicability to Ach...
 
Regenerative Medicine Track at Biotech Showcase 2012, San Francisco
Regenerative Medicine Track at Biotech Showcase 2012, San FranciscoRegenerative Medicine Track at Biotech Showcase 2012, San Francisco
Regenerative Medicine Track at Biotech Showcase 2012, San Francisco
 
Act corporate presentation may 2014 - print version
Act corporate presentation   may 2014 - print versionAct corporate presentation   may 2014 - print version
Act corporate presentation may 2014 - print version
 
The Lancet - Human embryonic stem cell-derived retinal pigment epithelium in...
The Lancet - Human embryonic stem cell-derived retinal pigment  epithelium in...The Lancet - Human embryonic stem cell-derived retinal pigment  epithelium in...
The Lancet - Human embryonic stem cell-derived retinal pigment epithelium in...
 
Biotecnika Times newspaper Dated 1st Jan 2018
Biotecnika Times newspaper Dated 1st Jan 2018Biotecnika Times newspaper Dated 1st Jan 2018
Biotecnika Times newspaper Dated 1st Jan 2018
 
Rowitch, David
Rowitch, DavidRowitch, David
Rowitch, David
 

Último

Último (20)

ECS 2024 Teams Premium - Pretty Secure
ECS 2024   Teams Premium - Pretty SecureECS 2024   Teams Premium - Pretty Secure
ECS 2024 Teams Premium - Pretty Secure
 
Using IESVE for Room Loads Analysis - UK & Ireland
Using IESVE for Room Loads Analysis - UK & IrelandUsing IESVE for Room Loads Analysis - UK & Ireland
Using IESVE for Room Loads Analysis - UK & Ireland
 
Behind the Scenes From the Manager's Chair: Decoding the Secrets of Successfu...
Behind the Scenes From the Manager's Chair: Decoding the Secrets of Successfu...Behind the Scenes From the Manager's Chair: Decoding the Secrets of Successfu...
Behind the Scenes From the Manager's Chair: Decoding the Secrets of Successfu...
 
Microsoft CSP Briefing Pre-Engagement - Questionnaire
Microsoft CSP Briefing Pre-Engagement - QuestionnaireMicrosoft CSP Briefing Pre-Engagement - Questionnaire
Microsoft CSP Briefing Pre-Engagement - Questionnaire
 
Designing for Hardware Accessibility at Comcast
Designing for Hardware Accessibility at ComcastDesigning for Hardware Accessibility at Comcast
Designing for Hardware Accessibility at Comcast
 
AI mind or machine power point presentation
AI mind or machine power point presentationAI mind or machine power point presentation
AI mind or machine power point presentation
 
ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...
ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...
ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...
 
AI presentation and introduction - Retrieval Augmented Generation RAG 101
AI presentation and introduction - Retrieval Augmented Generation RAG 101AI presentation and introduction - Retrieval Augmented Generation RAG 101
AI presentation and introduction - Retrieval Augmented Generation RAG 101
 
Long journey of Ruby Standard library at RubyKaigi 2024
Long journey of Ruby Standard library at RubyKaigi 2024Long journey of Ruby Standard library at RubyKaigi 2024
Long journey of Ruby Standard library at RubyKaigi 2024
 
Continuing Bonds Through AI: A Hermeneutic Reflection on Thanabots
Continuing Bonds Through AI: A Hermeneutic Reflection on ThanabotsContinuing Bonds Through AI: A Hermeneutic Reflection on Thanabots
Continuing Bonds Through AI: A Hermeneutic Reflection on Thanabots
 
FDO for Camera, Sensor and Networking Device – Commercial Solutions from VinC...
FDO for Camera, Sensor and Networking Device – Commercial Solutions from VinC...FDO for Camera, Sensor and Networking Device – Commercial Solutions from VinC...
FDO for Camera, Sensor and Networking Device – Commercial Solutions from VinC...
 
Choosing the Right FDO Deployment Model for Your Application _ Geoffrey at In...
Choosing the Right FDO Deployment Model for Your Application _ Geoffrey at In...Choosing the Right FDO Deployment Model for Your Application _ Geoffrey at In...
Choosing the Right FDO Deployment Model for Your Application _ Geoffrey at In...
 
Integrating Telephony Systems with Salesforce: Insights and Considerations, B...
Integrating Telephony Systems with Salesforce: Insights and Considerations, B...Integrating Telephony Systems with Salesforce: Insights and Considerations, B...
Integrating Telephony Systems with Salesforce: Insights and Considerations, B...
 
Syngulon - Selection technology May 2024.pdf
Syngulon - Selection technology May 2024.pdfSyngulon - Selection technology May 2024.pdf
Syngulon - Selection technology May 2024.pdf
 
Intro in Product Management - Коротко про професію продакт менеджера
Intro in Product Management - Коротко про професію продакт менеджераIntro in Product Management - Коротко про професію продакт менеджера
Intro in Product Management - Коротко про професію продакт менеджера
 
How Red Hat Uses FDO in Device Lifecycle _ Costin and Vitaliy at Red Hat.pdf
How Red Hat Uses FDO in Device Lifecycle _ Costin and Vitaliy at Red Hat.pdfHow Red Hat Uses FDO in Device Lifecycle _ Costin and Vitaliy at Red Hat.pdf
How Red Hat Uses FDO in Device Lifecycle _ Costin and Vitaliy at Red Hat.pdf
 
WSO2CONMay2024OpenSourceConferenceDebrief.pptx
WSO2CONMay2024OpenSourceConferenceDebrief.pptxWSO2CONMay2024OpenSourceConferenceDebrief.pptx
WSO2CONMay2024OpenSourceConferenceDebrief.pptx
 
IESVE for Early Stage Design and Planning
IESVE for Early Stage Design and PlanningIESVE for Early Stage Design and Planning
IESVE for Early Stage Design and Planning
 
Your enemies use GenAI too - staying ahead of fraud with Neo4j
Your enemies use GenAI too - staying ahead of fraud with Neo4jYour enemies use GenAI too - staying ahead of fraud with Neo4j
Your enemies use GenAI too - staying ahead of fraud with Neo4j
 
The Metaverse: Are We There Yet?
The  Metaverse:    Are   We  There  Yet?The  Metaverse:    Are   We  There  Yet?
The Metaverse: Are We There Yet?
 

Dr Gerry Chader - AGM 2011 - Research Advancements

  • 1. Two Decades of Progress in Retinal Degeneration Research: 1990-2011 From Scientific Darkness to the Light of Clinical Trials ohenetihool L Gerald J. Chader, Ph.D., M.D.hc Doheny Eye Institute Los Angeles, CA USA os Angeles, CA University atlo October 22, 2009
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 23. Testing: Comparing Object Recognition using Argus 1 vs. Argus 2 Argus I (16 Electrodes)* Argus II (60 Electrodes) *AJO 2007, 143:820-827 Visual performance using a retinal prosthesis in three subjects with retinitis pigmentosa. Yani et al. 15 sec 2 sec
  • 24. Argus II patients Can Read Letters and Words Courtesy Drs. da Cruz and Webster (Moorfields Eye Hospital, London)
  • 25. Argus II Subjects Can Identify Numbers Courtesy Drs Sahel, Barale, Said, Scheer (Quinze-Vingts, Paris, France)
  • 26.
  • 27.
  • 28. This is NOT Vision of Terminator or Geordi from Star Trek…..Yet
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54. THANK YOU FOR YOUR ATTENTION!
  • 55.
  • 56.

Notas do Editor

  1. But pixel numbers do count